Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Department of Pathology and Laboratory Medicine, |
RCV001354547 | SCV001549192 | uncertain significance | Subcutaneous panniculitis-like T-cell lymphoma | no assertion criteria provided | clinical testing | The HAVCR2 p.R111Q variant was not identified in the literature nor was it identified ClinVar. The variant was identified in dbSNP (ID: rs367701067) and in control databases in 14 of 282336 chromosomes at a frequency of 0.00004959 (Genome Aggregation Database March 6, 2019, v2.1.1). The p.R111 residue is conserved in mammals and computational analyses (MUT Assesor, PolyPhen-2, SIFT, MutationTaster, Revel, FATHMM, MetaLR, DANN) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (Splice AI exome) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. |